Table 1 Baseline characteristics of the patients included in the study
From: Alactic base excess predicts the use of renal replacement therapy in patients with septic shock
Variable | Renal replacement therapy | ||
|---|---|---|---|
Total n = 164 | Yes n = 68 | No n = 96 | |
Age, years old (IQR) | 59 (46–69) | 59 (48–68) | 60 (45–74) |
Gender | |||
Female n (%) | 85 (51.8) | 39 (57.4) | 46 (47.9) |
Male n (%) | 79 (48.2) | 29 (42.6) | 50 (52.1) |
Comorbidities n (%) | |||
DM, Yes | 73 (44.5) | 34 (50.0) | 39 (40.6) |
SAH, Yes | 82 (50.0) | 40 (58.8) | 42 (43.8) |
Heart disease, Yes | 23 (14.0) | 8 (11.8) | 15 (15.6) |
Etiology, n (%) | |||
Lung, Yes | 68 (41.5) | 20 (29.4) | 48 (50.0) |
Abdominal, Yes | 64 (39.0) | 34 (50.0) | 30 (31.3) |
Urinary, Yes | 24 (14.6) | 12 (17.6) | 12 (12.5) |
Soft tissues, Yes | 3 (1.8) | 1 (1.5) | 2 (2.1) |
Other | 5 (3.0) | 1 (1.5) | 4 (4.2) |
Norepinefrine mcg/kg/min (IQR) | 0.32 (0.21–0.48) | 0.33 (0.22–0.52) | 0.30 (0.21–0.45) |
Inotropic, Yes n (%) | 21 (12.8) | 8 (11.8) | 13 (13.5) |
MV days (IQR) | 4 (3–8) | 5 (3–8) | 4 (2–8) |
ICU stay days (IQR) | 5 (3–9) | 5 (3–9) | 6 (3–8) |
SAPS II points (IQR) | 71 (64–80) | 72 (65–80) | 70 (63–80) |
Mortality, YES n (%) | 83 (50.6) | 40 (58.8) | 43 (44.8) |